V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036734 | 210008713 | 1.43 | 78.6 | Palliative (P) | 2019-06-20 | 2019-06-20 | Lomustine | 02 | N | 210016207 | LOMUSTINE |
| 210036736 | 210008730 | 1.74 | 57.6 | Palliative (P) | 2018-08-10 | 2018-08-13 | Lomustine | 02 | N | 210016258 | LOMUSTINE |
| 210036737 | 210008736 | null | 66 | Curative (C) | 2017-11-29 | 2017-11-29 | Rituximab | N | N | 210016266 | RITUXIMAB |
| 210036738 | 210030603 | 1.78 | null | Adjuvant (A) | 2014-11-08 | 2014-12-04 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 210016287 | RITUXIMAB |
| 210036739 | 210008753 | 1.74 | 74.6 | Palliative (P) | 2014-10-02 | 2015-03-30 | Lomustine | 2 | N | 210016296 | LOMUSTINE |
| 210036740 | 210036824 | null | 64 | Palliative (P) | 2014-05-01 | 2014-05-23 | Lomustine | 02 | N | 210016307 | LOMUSTINE |
| 210036741 | 210008756 | 1.66 | 101.6 | Palliative (P) | 2013-06-26 | 2014-02-21 | Lomustine | 2 | N | 210016308 | LOMUSTINE |
| 210036742 | 210008765 | 1.68 | 101 | Curative (C) | 2017-07-29 | 2017-09-14 | Rituximab | N | N | 210016332 | RITUXIMAB |
| 210036743 | 210008778 | 1.82 | 87.1 | Palliative (P) | 2017-06-06 | 2017-06-06 | Lomustine | N | N | 210016344 | LOMUSTINE |
| 210036744 | 210019555 | 1.62 | 68.5 | Curative (C) | 2016-12-17 | 2016-12-17 | Rituximab | N | N | 210016374 | RITUXIMAB |
| 210036745 | 210008795 | 1.87 | 109.6 | Disease modification (D) | 2015-10-20 | 2015-10-20 | IBRUTINIB | Y | N | 210016377 | IBRUTINIB |
| 210036746 | 210037398 | 1.81 | 97 | Curative (C) | 2015-05-27 | 2016-03-22 | Lomustine | Y | N | 210016429 | LOMUSTINE |
| 210036747 | 210008845 | 1.82 | 65.3 | Curative (C) | 2013-04-27 | 2014-02-19 | Rituximab | N | N | 210016611 | RITUXIMAB |
| 210036748 | 210008909 | 1.72 | null | Palliative (P) | 2016-03-22 | 2016-03-22 | Lomustine | N | N | 210016886 | LOMUSTINE |
| 210036749 | 210008922 | 1.85 | 86.65 | Curative (C) | 2018-07-19 | 2018-07-19 | Rituximab | Y | N | 210016939 | RITUXIMAB |
| 210036750 | 210008931 | 1.73 | 95 | Disease modification (D) | 2016-05-25 | 2016-05-29 | Lomustine | 99 | N | 210016982 | LOMUSTINE |
| 210036751 | 210008935 | 1.62 | null | Palliative (P) | 2015-11-15 | 2015-11-20 | Lomustine | N | N | 210016990 | LOMUSTINE |
| 210036753 | 210008940 | 1.63 | 47.3 | Disease modification (D) | 2015-12-09 | 2015-12-10 | IBRUTINIB | N | N | 210017000 | IBRUTINIB |
| 210036754 | 210019646 | 1.73 | 93.7 | Palliative (P) | 2014-06-04 | 2015-02-23 | Rituximab | N | N | 210017034 | RITUXIMAB |
| 210036755 | 210008950 | 0 | 45.6 | Not known (9) | 2015-07-01 | 2015-07-03 | Lomustine | null | N | 210017042 | LOMUSTINE |
| 210036756 | 210008958 | null | 56.8 | Adjuvant (A) | 2017-11-01 | 2018-01-02 | Rituximab | 2 | N | 210017073 | RITUXIMAB |
| 210036757 | 210008963 | 1.73 | null | Palliative (P) | 2014-04-19 | 2014-06-26 | Bendamustine+Rituximab (1st Course) | 2 | N | 210017102 | BENDAMUSTINE + RITUXIMAB |
| 210036758 | 210008967 | 1.77 | 87 | Curative (C) | 2013-12-05 | 2014-10-19 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 1 | N | 210017106 | FCR |
| 210036759 | 210008968 | 1.6 | 50.6 | Curative (C) | null | 2016-10-30 | FCR Oral - Cycle 2 onwards | null | null | 210017119 | FCR |
| 210036760 | 210008973 | 0 | 19 | Curative (C) | 2018-10-05 | 2018-11-16 | VINCRISTINE | null | N | 210017129 | VINCRISTINE |
| 210036761 | 210008976 | null | null | Disease modification (D) | null | 2018-10-08 | VINCRISTINE | Y | N | 210017141 | VINCRISTINE |
| 210036762 | 210008980 | 1.81 | 84 | Curative (C) | 2016-05-05 | 2016-09-15 | FLAIR Trial | Y | N | 210017152 | FLAIR TRIAL |
| 210036763 | 210019675 | 1.71 | 25 | Curative (C) | 2015-09-23 | 2016-09-22 | VINCRISTINE | N | N | 210017169 | VINCRISTINE |
| 210036764 | 210008993 | 1.78 | 82.3 | Palliative (P) | 2014-10-29 | 2015-01-12 | Vincristine (weekly) | N | N | 210017201 | VINCRISTINE |
| 210036765 | 210019681 | null | 83 | Curative (C) | 2018-04-15 | 2018-04-15 | FLAIR Trial | N | N | 210017207 | FLAIR TRIAL |
| 210036766 | 210009008 | 0 | 102.9 | Palliative (P) | 2016-08-12 | 2016-11-09 | FLAIR Trial | N | null | 210017279 | FLAIR TRIAL |
| 210036768 | 210009023 | 0 | null | Palliative (P) | 2018-08-05 | 2018-08-05 | FCR Oral - Cycle 2 onwards | N | null | 210017387 | FCR |
| 210036769 | 210009027 | 1.71 | 68 | Palliative (P) | 2014-04-13 | 2014-04-17 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | Y | 210017394 | FCR |
| 210036770 | 210026581 | 1.7 | 31.9 | Curative (C) | 2017-05-13 | 2017-05-20 | FCR Oral - Cycle 2 onwards | Y | N | 210017405 | FCR |
| 210036771 | 210026583 | 0 | 78.5 | Curative (C) | 2017-04-14 | 2017-05-22 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210017421 | CHLORAMBUCIL + RITUXIMAB |
| 210036772 | 210009040 | 0 | 60.4 | Curative (C) | 2017-01-07 | 2017-04-15 | ALL UKALL60+ TRIAL | Y | N | 210017422 | UKALL60+ |
| 210036773 | 210009045 | 1.71 | 74.4 | Curative (C) | 2014-12-28 | 2015-01-25 | Triple / Double Intrathecal Therapy | Y | N | 210017447 | TRIPLE INTRATHECAL |
| 210036774 | 210009052 | 1.9 | 84 | Palliative (P) | 2017-06-21 | 2017-06-30 | Triple / Double Intrathecal Therapy | N | N | 210017471 | TRIPLE INTRATHECAL |
| 210036775 | 210009058 | null | 92.3 | Disease modification (D) | 2016-03-18 | 2016-04-15 | Triple Intrathecal | N | N | 210017476 | TRIPLE INTRATHECAL |
| 210036776 | 210009064 | 1.62 | 57.2 | Curative (C) | 2018-08-13 | 2018-11-13 | ALL UKALL2003 TRIAL | Y | N | 210017486 | UKALL 2003 |
| 210036777 | 210019735 | 1.58 | null | Curative (C) | 2013-11-25 | 2014-01-10 | IDELALISIB + RITUXIMAB | null | null | 210017519 | IDELALISIB + RITUXIMAB |
| 210036778 | 210009076 | null | 85.899 | Curative (C) | 2014-09-30 | 2015-01-01 | ALL UKALL2003 TRIAL | N | null | 210017522 | UKALL 2003 |
| 210036779 | 210009089 | 0 | 65.2 | Palliative (P) | 2017-03-22 | 2017-10-01 | ALL UKALL60+ TRIAL | Y | N | 210017549 | UKALL60+ |
| 210036780 | 210009117 | null | 77.75 | Curative (C) | 2015-05-18 | 2015-05-18 | METHOTREXATE | N | null | 210017673 | METHOTREXATE |
| 210036782 | 210019828 | 1.78 | null | Neo-adjuvant (N) | null | 2017-04-26 | Imatinib 400mg | N | N | 210018045 | IMATINIB |
| 210036783 | 210009217 | 1.58 | null | Disease modification (D) | 2017-01-28 | 2017-03-30 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | 210018065 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210036784 | 210009225 | 0 | 78.5 | Palliative (P) | 2018-07-11 | 2018-11-21 | IMATINIB | 01 | N | 210018080 | IMATINIB |
| 210036786 | 210009266 | 1.54 | 43.6 | null | null | 2016-10-28 | IMATINIB | Y | N | 210018243 | IMATINIB |
| 210036787 | 210019876 | 0 | 69 | Disease modification (D) | 2016-12-20 | 2017-02-13 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210018266 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210036788 | 210009283 | 1.69 | 52 | Disease modification (D) | 2016-11-18 | 2017-02-18 | Triple Intrathecal | Y | N | 210018278 | TRIPLE INTRATHECAL |